Specific technologies and broad technology platforms have tremendous potential for market growth based on combinations of recent technology advancement, changes in clinical practice, current forces in the market and other criterial. Biotech solutions to traditional medical device technologies. The thrust of medical technology is, and has been for a long time, to make it as effective [...]
¶
Posted 18 February 2009
† P. Driscoll
§
ablation § biomaterials § biotech § cancer § cardiology § diabetes § diagnostics § drug § gastroenterology § innovation § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § pharmaceutical § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: ablation, anti-adhesion, cancer, cardiology, cyanoacrylate, diabetes, disc replacement, drug, fibrin glue, fibrin sealant, gastroenterology, hemostasis, innovation, market data, medical adhesive, medtech, microwave ablation, nanotech, neurology, obesity, ophthalmology, orthopedic, radiofrequency ablation, spine surgery, startups, surgical glue, surgical sealant, suture, thermal ablation, tissue engineering, ultrasound, wound closure, wound management
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones. At right is shown the forecast, by modality type, of ablation and other energy-based therapies through 2017. The most significant growth is expected to [...]
¶
Posted 18 August 2008
† P. Driscoll
§
ablation § cardiology § innovation § market data § medtech § orthopedic § spine § surgery § urogenital § wound management
‡
°
Also tagged: ablation, cardiology, cryo, hifu, hydromechanical, innovation, laser, market data, medtech, microwave, orthopedic, radiation, radiofrequency, spine, surgery, thermal, ultrasound, wound management
The post below has been superceded by the 2010 analysis, "Ablation Technologies Worldwide Market 2009-2019". See link for details. See also "Japanese Ablation Market", "Cryotherapy and Cryosurgery", and "Radiofrequency ablation devices". (See July 2010 report #A145, "Ablation Technologies Worldwide Market, 2009-2019," from MedMarket Diligence, LLC. May be purchased online.) Energy-based therapies generate sales of $13 [...]
¶
Posted 11 July 2008
† P. Driscoll
§
ablation § cancer § cardiology § gastroenterology § innovation § market data § medtech § orthopedic § spine § surgery § urogenital § wound management
‡
°
Also tagged: ablation, cryo, energy-based, gastroenterology, hifu, laser, medtech, microwave, oncology, orthopedics, prostate, radiofrequency, surgery, thermal, ultrasound
Below is the coverage in the April 2008 issue of MedMarkets. Ablation: An Energized Market Demand for Hip and Knee Implants Expected to Increase MedMarket Outlook: Beyond Technology Innovation: Current and Future Market Forces and Trends Early Stage Companies: Evalve, ES Vascular, Cardiorobotics, TriVascular Early Stage Company Financings: Alure Medical, Arbel Medical, Breathe Technologies, CoAxia, [...]
¶
Posted 13 May 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, innovation, market data, medtech, nanotech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, wound management
We have just updated our “High Growth Medical Technologies” white paper, as we expect to continually do in the immediate future, since the areas with growth keep changing, and new areas keep appearing. As all white papers should be, it’s free. Here’s the link so you can download it. bookmark to
¶
Posted 09 April 2008
† P. Driscoll
§
biotech § cancer § cardiology § drug § gastroenterology § innovation § market data § medtech § nanotech § neurology § obesity § ophthalmology § orthopedic § spine § startups § surgery § tissue engineering § urogenital § wound management
‡
°
Also tagged: biotech, cancer, cardiology, drug, gastroenterology, innovation, market data, medtech, nanotech, neurology, obesity, ophthalmology, orthopedic, spine, startups, surgery, tissue engineering, wound management
New companies in the medical technology industry are pursuing technologies to make existing technologies obsolete, expand existing markets, create new markets and otherwise tap into demand for new solutions in healthcare. The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in the Startups coverage in [...]
Not every start-up succeeds. But every single successful medical technology company was once a start-up. From a primary consideration, start-up companies have been founded based on: (1) what technologies they consider possible, and (2) the need for clinical solutions to problems that exist in health care. For this reason, we look at the range of [...]
The terms “sealant” and “glue” tend to be used interchangeably in the surgical context, but in fact there is a difference in adhesive strength between sealants, pioneered by fibrin products (sometimes homemade) and the later, stronger glues of which cyanoacrylate-based products were the leaders. Fibrin sealants represented a revolution in local hemostatic measures for both [...]
Bulking Agents for Stress UI One important weapon in the arsenal of noninvasive or minimally invasive therapies for Stress Urinary Incontinence (SUI) comprises bulking agents—injectable substances that expand the intrinsic sphincter of the bladder, allowing it to withstand greater pressures. There are several companies exploring or developing bulking agents for SUI (see chart). For many [...]
Company Steadily Secures the Urogenital Treatment Market The acquisition of Laserscope by American Medical Systems Holdings this month for $715 million adds a certain punctuation to AMSH’s steadily growing presence in the field of urogenital medicine or, as the company refers to it, “pelvic health.” Lest there be any doubt, AMSH has been on a [...]